Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 6 Summary minute ventilation (VE, L/min) measures resulting from five upper body power tests

From: Influence of an alkalizing supplement on markers of endurance performance using a double-blind placebo-controlled design

Group Test
Period
Constant
Power Test
UBP10
Test
Trial #1
UBP10
Test
Trial #2
UBP10
Test
Trial #3
UBP60
Test
Placebo
(n = 12)
Pre-Test 100.6 ± 11.5 87.9 ± 10.0 99.4 ± 10.2 110.4 ± 9.4 147.2 ± 12.1
  Post-Test 100.7 ± 13.2 92.3 ± 9.9 109.8 ± 9.9 113.9 ± 10.1 148.6 ± 13.2
Treatment
(n = 12)
Pre-Test 104.6 ± 11.7 102.9 ± 7.7 126.0 ± 12.8 129.7 ± 10.3 163.5 ± 12.0
  Post-Test 101.7 ± 10.6 97.3 ± 9.8 122.4 ± 11.8 132.1 ± 12.9 †153.3 ± 11.1
  1. NOTE: All values expressed as Mean ± SE; UBP10 = 10-sec upper body power test; UBP60 = 60-sec upper body power test
  2. †Post-test measure of VE for UPB60 test was nearly significantly lower than pre-test measures within the treatment group (P < 0.10)